Dr. Hotez with Baylor College of Medicine says the latest wave of infections are likely caused by the new Omicron sub-variant, B-A.5. The CDC now considers it the dominant strain in the U.S.
The nation’s youngest children are getting their chance at vaccines for COVID-19. Shots began Monday at a few locations, though they were expected to ramp up after the Juneteenth federal holiday.
Starting Tuesday, the Texas Children's Hospital will be administering COVID-19 vaccines to children aged 6 months to 5 years old.
The CDC recommends how to use vaccines and its vaccine advisers are set to discuss the shots for the youngest kids Friday and vote on Saturday.
COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.
An FDA advisory panel endorsed on Tuesday Moderna's COVID-19 vaccine for teenagers and school-aged children.
Up to 20 million U.S. children under 5 could be eligible for a COVID-19 vaccine starting the week of June 20.
Pfizer’s COVID-19 booster shot for U.S. kids ages 5 to 11 has been approved by the FDA. Next, it will need the CDC’s final sign-off.
Hotez, who is the Dean for the National School of Tropical Medicine at the Baylor College of Medicine, said he has ‘moderate’ symptoms of fatigue, headache and sore throat.'
“Thankfully, I am feeling ok with what appears to be a mild case of COVID-19,” Commissioner Garcia said. "I am grateful to have been vaccinated and boosted which I maintain is the reason my symptoms aren’t worse."
Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
“With many taking advantage of widely available vaccines, booster shots, and the robust COVID-19 testing, our country and more importantly, our community has moved into a new phase of this pandemic,” Mayor Sylvester Turner said
Children under 5 are the only group in the U.S. not yet eligible for a COVID-19 vaccination.
Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant.
Pfizer said new data shows its kid-sized COVID-19 booster could help healthy elementary-aged children rev up virus-fighting antibodies and plans to seek authorization soon.
The study found that after a booster vaccination, levels of antibodies in the blood that could bind to and neutralize a new omicron variant increased substantially.
The Food and Drug Administration authorized a second COVID-19 booster for many Americans. Here's a look at who is eligible and when to get it.
President Joe Biden received his second COVID-19 booster while asking Congress for more funding and rolling out a new website.
U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.